Full history for every metric is available with a Kvantra account
RMH Holdings Limited (8437.HK)
Key financial summary
Financials in SGD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SGD m | 7 | 8 | 0 | 4 | 3 | 5 | 2 |
| Operating profit | SGD m | -3 | -3 | |||||
| Net profit | SGD m | 0 | -9 | -9 | -19 | -7 | -4 | -5 |
| EPS reported | SGD | -0.05 | -0.07 | |||||
| Operating cashflow per share | SGD | 0.00 | -0.02 | |||||
| Capex per share | SGD | 0.00 | 0.00 | |||||
| FCF per share | SGD | 0.00 | -0.02 | |||||
| Free cash flow | SGD m | 0 | -9 | |||||
| Net debt | SGD m | -0 | 0 | |||||
| Book value equity | SGD m | -19 | -19 | |||||
| Book value per share | SGD | -0.29 | -0.29 | |||||
| Number of shares | m | 66.6 | 66.6 | |||||
| DPS (TTM paid) | SGD | 0.00 | 0.00 |
Financial summary
Financials in SGD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.15 | -0.14 | |||||
| P/S LTM | x | 0.59 | 1.22 | |||||
| P/FCF LTM | x | 26.41 | -0.32 | |||||
| EV/EBITDA LTM | x | -2.58 | -0.71 | |||||
| EV/Sales LTM | x | 1.33 | 1.23 | |||||
| Earnings Yield LTM | % | -117.48% | -13.89% | |||||
| FCF Yield | % | 3.79% | -313.39% | |||||
| Quality | ||||||||
| ROE | % | 17.98% | 1.96% | |||||
| ROIC | % | 14.91% | -2.09% | |||||
| Operating margin | % | -59.52% | 17.76% | |||||
| Gross margin | % | 62.47% | 32.09% | |||||
| FCF/Sales | % | 2.24% | -64.85% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +58.62% | -67.68% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | -69.29% | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.03 | -2.07 | |||||
| Net Debt/EBITDA | x | -1.43 | -16.73 | |||||
| EBIT/Net interest | x | -12.83 | 2.80 | |||||
| Net debt/market cap | % | -15.21% | 0.99% | |||||
| Net debt/Equity | x | 0.02 | -0.00 | |||||
| Gross debt/equity | x | -0.22 | -0.21 | |||||
Company overview
RMH Holdings Limited, an investment holding company headquartered in Singapore and incorporated in 2017, delivers a diverse range of medical, dermatological, and aesthetic products and services across Singapore, Hong Kong, and international markets. The company operates through two primary segments: Healthcare Service and Trading Sales. Its healthcare division specializes in comprehensive care for dermatological conditions affecting the skin, hair, and nails, employing medical, surgical, laser, and aesthetic treatments. This includes addressing issues such as skin cancer, eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts, in addition to providing consultancy, prescription, and dispensing services. The trading segment focuses on the distribution of health supplements and various medical products, including hand sanitizers, disposable medical masks, and other essential medical supplies. RMH Holdings manages an extensive network of facilities, comprising seven dermatology and surgery clinics, one aesthetic and laser center, one multi-specialists center, and one regenerative medicine center.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
RMH Holdings Limited (8437.HK)
RMH Holdings Limited, an investment holding company headquartered in Singapore and incorporated in 2017, delivers a diverse range of medical, dermatological, and aesthetic products and services across Singapore, Hong Kong, and international markets. The company operates through two primary segments: Healthcare Service and Trading Sales. Its healthcare division specializes in comprehensive care for dermatological conditions affecting the skin, hair, and nails, employing medical, surgical, laser, and aesthetic treatments. This includes addressing issues such as skin cancer, eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts, in addition to providing consultancy, prescription, and dispensing services. The trading segment focuses on the distribution of health supplements and various medical products, including hand sanitizers, disposable medical masks, and other essential medical supplies. RMH Holdings manages an extensive network of facilities, comprising seven dermatology and surgery clinics, one aesthetic and laser center, one multi-specialists center, and one regenerative medicine center.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free